Laboratory Strategies for Diagnosis and Monitoring of Hepatis C Virus Infection

[1]  K. Hagymási.  The Nobel Prize in Physiology or Medicine—2020 , 2021, Structural Chemistry.

[2]  J. Pawlotsky,et al.  Impact of COVID-19 on global HCV elimination efforts , 2020, Journal of Hepatology.

[3]  A. Moorman,et al.  Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  K. Buchacz,et al.  Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection — U.S. Public Health Service Guideline, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[5]  Stephen R. Spriggs,et al.  CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[6]  M. Ghany,et al.  Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection , 2020 .

[7]  J. Quer,et al.  Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination? , 2019, Journal of Clinical Microbiology.

[8]  A. Mangia,et al.  Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras , 2019, Journal of Clinical Microbiology.

[9]  H. El‐Serag,et al.  Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey , 2019, Journal of viral hepatitis.

[10]  P. Patel,et al.  Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention , 2019, Seminars in dialysis.

[11]  Kevin J. Moore,et al.  Prevalence and sociodemographic disparities of Hepatitis C in Baby Boomers and the US adult population. , 2019, Journal of infection and public health.

[12]  L. Kucirka,et al.  The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States , 2018, Annals of Internal Medicine.

[13]  A. Hatzakis,et al.  Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0 , 2017, Virology Journal.

[14]  J. V. D. van der Meer,et al.  Spontaneous Clearance of Hepatitis C Virus Infection Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men , 2017, Open forum infectious diseases.

[15]  J. Macías,et al.  HCV epidemiology in high-risk groups and the risk of reinfection. , 2016, Journal of hepatology.

[16]  H. Hagan,et al.  Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis , 2016, BMC Infectious Diseases.

[17]  P. Easterbrook,et al.  Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[18]  Richard H. Liang,et al.  The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study. , 2016, The Lancet. Infectious diseases.

[19]  Ding‐Shinn Chen,et al.  Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping , 2015, Journal of Clinical Microbiology.

[20]  A. Flaxman,et al.  Global Distribution and Prevalence of Hepatitis C Virus Genotypes , 2014, Hepatology.

[21]  L. Abu-Raddad,et al.  Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Ward,et al.  Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians , 2013, MMWR. Morbidity and mortality weekly report.

[23]  J. Washington,et al.  HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease , 2013, Annals of Internal Medicine.

[24]  F. Penin,et al.  Hepatitis C virus proteins: from structure to function. , 2013, Current topics in microbiology and immunology.

[25]  Atlanta,et al.  Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. , 2011, MMWR. Morbidity and mortality weekly report.

[26]  M. Ghany,et al.  Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.

[27]  S. Ray,et al.  Acute hepatitis C , 2008, The Lancet.

[28]  C. Schaper,et al.  Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0 , 2008, Journal of Clinical Microbiology.

[29]  K. Patel,et al.  Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. , 2007, The Journal of pediatrics.

[30]  G. Luo,et al.  Role of the 5′-Proximal Stem-Loop Structure of the 5′ Untranslated Region in Replication and Translation of Hepatitis C Virus RNA , 2003, Journal of Virology.

[31]  M. Alter,et al.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[32]  Jean-Michel Pawlotsky,et al.  Hepatitis C virus genetic variability: pathogenic and clinical implications. , 2003, Clinics in liver disease.